Correlation Between Scpharmaceuticals and CannBioRx Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and CannBioRx Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and CannBioRx Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and CannBioRx Life Sciences, you can compare the effects of market volatilities on Scpharmaceuticals and CannBioRx Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of CannBioRx Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and CannBioRx Life.

Diversification Opportunities for Scpharmaceuticals and CannBioRx Life

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Scpharmaceuticals and CannBioRx is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and CannBioRx Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CannBioRx Life Sciences and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with CannBioRx Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CannBioRx Life Sciences has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and CannBioRx Life go up and down completely randomly.

Pair Corralation between Scpharmaceuticals and CannBioRx Life

Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the CannBioRx Life. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 3.86 times less risky than CannBioRx Life. The stock trades about -0.01 of its potential returns per unit of risk. The CannBioRx Life Sciences is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  4.99  in CannBioRx Life Sciences on August 25, 2024 and sell it today you would lose (4.11) from holding CannBioRx Life Sciences or give up 82.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.59%
ValuesDaily Returns

Scpharmaceuticals  vs.  CannBioRx Life Sciences

 Performance 
       Timeline  
Scpharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
CannBioRx Life Sciences 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CannBioRx Life Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating technical and fundamental indicators, CannBioRx Life showed solid returns over the last few months and may actually be approaching a breakup point.

Scpharmaceuticals and CannBioRx Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scpharmaceuticals and CannBioRx Life

The main advantage of trading using opposite Scpharmaceuticals and CannBioRx Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, CannBioRx Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CannBioRx Life will offset losses from the drop in CannBioRx Life's long position.
The idea behind Scpharmaceuticals and CannBioRx Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation